Table 2.
Plasma | Normal control | Infection control | Infected+ pefloxacin day 5 | Infected+ pefloxacin day 10 | Infected + pefloxacin day 15 | Infected+ amoxillin day 5 | Infected+ amoxillin day 10 | Infected + amoxillin day 15 |
---|---|---|---|---|---|---|---|---|
Cholesterol (mg/dl) |
56.60±2.43a |
104.13±6.60b |
79.14±5.49c |
79.04±5.84c |
77.96±5.73c |
59.86±7.54d |
73.55±7.05c |
69.16±6.70d |
Triacylglycerols (mg/dl) |
63.18±5.19a |
125.18±14.26c |
77.32±0.99b |
97.48±10.89c |
58.43±5.89a |
112.78±6.78d |
127.58±17.61d |
68.16±3.72b |
Phospholipid (mg/dl) |
75.33±15.41a |
129.60±23.13c |
122.96±7.93c |
100.60±15.55b |
109.84±10.18b |
130.25±18.29c |
109.35±10.40b |
66.10±20.74a |
Free Fatty acid (mg/dl) |
14.10±2.25a |
23.08±0.75c |
17.20±0.39b |
16.50±1.23b |
17.28±0.55b |
17.70±1.18b |
16.16±0.53b |
18.87±0.74b |
HDL | ||||||||
Cholesterol (mg/dl) |
39.06±2.77b |
22.19±0.94a |
21.08±4.03a |
37.19±8.41b |
21.16±1.39a |
18.06±5.97a |
36.76±2.74b |
22.36±1.75a |
Triacylglycerols (mg/dl) |
26.83±3.65a |
37.75±7.17a |
25.12±3.63a |
33.98±3.43a |
25.81±2.29a |
28.26±5.51a |
27.28±4.08a |
39.50±4.14a |
Phospholipid (mg/dl) |
68.53±1.42a |
29.57±1.71b |
89.91±19.50e |
73.87±12.24d |
52.49±7.31c |
71.93±7.31d |
66.10±14.67d |
48.60±7.37c |
LDL-VLDL | ||||||||
Cholesterol (mg/dl) |
25.94±2.31b |
49.03±2.39e |
15.24±2.32a |
43.38±3.75e |
36.17±3.23d |
28.64±3.34c |
43.38±3.00e |
34.33±3.80d |
Triacylglycerols (mg/dl) |
22.43±1.72a |
68.66±4.26d |
24.02±1.40a |
56.50±8.71c |
36.90±1.58b |
28.61±2.78a |
49.05±3.57c |
58.37±7.38d |
Phospholipid (mg/dl) | 86.99±2.81a | 95.18±5.63c | 64.64±4.04b | 110.81±2.73c | 107.41±2.14c | 69.50±4.18b | 117.13±9.23d | 83.11±4.31a |
Each value represents the mean±S.E.M of 5 rats. Values within the same row with different superscripts are significantly different at p<0.05.